Prediction market traders say an Anthropic IPO is near-certain this year after company filed with SEC

Anthropic unveiled its Form S-1, advancing a potential IPO that Kalshi traders assign a 95% chance of being officially announced by the end of 2026. The filing envisions Nasdaq ticker “ANT”; a Wall Street Journal report says Anthropic is aiming to start trading the week of Nov. 16, while Kalshi traders put the chance of trading before then at 14% and Polymarket traders assign a 69% chance of listing and opening by Nov. 20.

Analysis

For Nasdaq, Inc. (NDAQ), a successful listing would offer incremental listing and trading activity, but the article provides no deal size, final venue, or fee economics to support a material earnings revision. Treat this as a sentiment catalyst, not a fundamental catalyst. The intended Nasdaq ticker is evidence of direction, not confirmation of the final listing venue.

The more consequential read-through is price discovery for private AI valuations. Strong demand and a robust valuation could improve financing conditions for other AI companies and support risk appetite for AI infrastructure; a weak book or postponement could instead reset private marks and pressure the sector’s multiple. A high-profile offering may also compete for investor capital with other growth issuers, though the size of that effect is unknown.

Near term, prediction-market odds are not reliable confirmation: the cited platforms use different definitions and give materially different estimates for timing. Over the next 1–3 months, watch for an effective registration, confirmed exchange, pricing range, and evidence of institutional demand. Over 6–18 months, the key signal is whether public investors accept private-market AI valuations. The thesis weakens if the offering is delayed, lists elsewhere, or prices below indicated expectations; it strengthens for NDAQ only if the venue is confirmed and trading activity is meaningful. No material NDAQ trade is warranted on this information alone.

Key Decisions for Investors

• Do not buy NDAQ solely on the IPO headline: likely incremental economics are unquantified and may be immaterial to consolidated results.
• Track the final exchange, offering size, pricing range, and aftermarket liquidity; upgrade the NDAQ read-through only if Nasdaq is confirmed and activity appears significant.
• Use the deal as a conditional AI sentiment indicator: strong demand may support private AI valuations, while a delay or weak pricing could pressure them. Do not infer either outcome from prediction-market odds.
• Falsifiers: registration or listing delay, a venue other than Nasdaq, pricing materially below the eventual range, or weak trading after the offering.